Income Statement (ASTRIA/THERAPEUTICS)

Technical Analysis Historical Data Financials News & Analysis

ASTRIA/THERAPEUTICS NEWS

Astria Therapeutics, Inc. (NASDAQ:ATXS) Receives Consensus Ranking of “Purchase” from Analysts By MarketBeat - 2 days ago

Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has earned a consensus rating of “Buy” from the seven ratings firms that are covering the firm, MarketBeat.com reports. Five equities researc… [+3728 chars]...

Read more
4,600 Stocks in Astria Therapeutics, Inc. (NASDAQ:ATXS) Bought via KLP Kapitalforvaltning AS By MarketBeat - 2 weeks ago

KLP Kapitalforvaltning AS purchased a new position in Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm purchased 4,600 shares of th… [+3947 chars]...

Read more
Brokerages Set Astria Therapeutics, Inc. (NASDAQ:ATXS) Goal Worth at $26.60 By MarketBeat - 4 weeks ago

Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has received an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. … [+4007 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		182 -0.3
-0.16%
CVX 		139.3 -0.8
-0.57%
CAT 		307.4 0.34
0.11%
INTC 		20.34 -0.17
-0.83%
MSFT 		394.04 2.88
0.74%
DIS 		91.17 1.01
1.12%
DOW 		30.65 0.7
2.34%
CSCO 		57.34 0.5
0.88%
GS 		548.92 2.52
0.46%